Not logged in Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer Dilly, Julien; Hoffman, Megan T.; Abbassi, Laleh; Li, Ziyue; Paradiso, Francesca; Parent, Brendan D.; Hennessey, Connor J.; Jordan, Alexander C.; Morgado, Micaela; Dasgupta, Shatavisha; Uribe, Giselle A.; Yang, Annan; Kapner, Kevin S.; Hambitzer, Felix P.; Qiang, Li; Feng, Hanrong; Geisberg, Jacob; Wang, Junning; Evans, Kyle E.; Lyu, Hengyu; Schalck, Aislyn; Feng, Ningping; Lopez, Anastasia M.; Bristow, Christopher A.; Kim, Michael P.; Rajapakshe, Kimal I.; Bahrambeigi, Vahid; Roth, Jennifer A.; Garg, Kavita; Guerrero, Paola A.; Stanger, Ben Z.; Cristea, Simona; Lowe, Scott W.; Baslan, Timour; Van Allen, Eliezer M.; Mancias, Joseph D.; Chan, Emily; Anderson, Abraham; Katlinskaya, Yuliya V.; Shalek, Alex K.; Hong, David S.; Pant, Shubham; Hallin, Jill; Anderes, Kenna; Olson, Peter; Heffernan, Timothy P.; Chugh, Seema; Christensen, James G.; Maitra, Anirban; Wolpin, Brian M.; Raghavan, Srivatsan; Nowak, Jonathan A.; Winter, Peter S.; Dougan, Stephanie K.; Aguirre, Andrew J. Share Save
Biomarkers of acquired resistance to sotorasib (soto) plus panitumumab (pani) in chemorefractory KRAS G12C-mutated metastatic colorectal cancer (mCRC) Hong, David S.; Kuboki, Yasutoshi; Yaeger, Rona; Strickler, John H.; Masuishi, Toshiki; Langer, Corey; Shergill, Ardaman; Kim, Edward; Hindoyan, Antreas; Tran, Qui; Mukundan, Lata; Chan, Emily; Anderson, Abraham; Fakih, Marwan G. Share Save
Dynamic changes in circulating tumor DNA (ctDNA) in patients treated with sotorasib for KRAS G12C mutant non-small cell lung cancer Murciano-Goroff, Yonina R.; Skoulidis, Ferdinandos; Velcheti, Vamsidhar; Falchook, Gerald S.; Dy, Grace; Ramalingam, Suresh; Edelman, Martin J.; Wolf, Jurgen; Italiano, Antoine; Reis-Filho, Jorge S.; Razavi, Pedram; Drilon, Alexander; Misale, Sandra; Yaeger, Rona; Li, Mark; Hindoyan, Antreas; Ang, Agnes; Anderson, Abraham A.; Hong, David; Lito, Piro; Govindan, Ramaswamy; Li, Bob T. Share Save
A phase 1b study evaluating the combination of sotorasib, a KRASG12C inhibitor, and afatinib, a pan-ErbB tyrosine kinase inhibitor, in advanced KRAS p.G12C mutated non-small cell lung cancer (NSCLC) Gandara, David; Marrone, Kristen; Govindan, Ramaswamy; Skoulidis, Ferdinandos; Durm, Gregory; Clarke, Jeffrey; Frank, Richard; Krauss, John; Snyder, Wendy; Dai, Tian; Mather, Omar; Cifuentes, Paul; Hindoyan, Antreas; Anderson, Abraham; Burns, Timothy Share Save
Biomarker analysis from a phase Ib, multicenter, open-label clinical trial of talimogene laherparepvec (T-VEC) injected (inj) into metastatic and primary liver tumors Hecht, J. R.; Peeters, M.; Jimenez, M. Martin; Pless, M.; Cubillo, A.; Garcia-Corbacho, J.; Mach, N.; Digklia, A.; Park, H.; Subbiah, V.; Gorski, K.; Anderson, A.; Liu, C.; Snyder, W.; Chesney, J. Share Save
Neoadjuvant talimogene laherparepvec plus surgery versus surgery alone for resectable stage IIIB-IVM1a melanoma: a randomized, open-label, phase 2 trial Dummer, R.; Gyorki, D. E.; Hyngstrom, J.; Berger, A. C.; Conry, R.; Demidov, L.; Sharma, A.; Treichel, S. A.; Radcliffe, H.; Gorski, K. S.; Anderson, A.; Chan, E.; Faries, M.; Ross, M. I. Share Save
Sotorasib for Lung Cancers with KRAS p.G12C Mutation Skoulidis, Ferdinandos; Li, Bob T.; Dy, Grace K.; Price, Timothy J.; Falchook, Gerald S.; Wolf, Jurgen; Italiano, Antoine; Schuler, Martin; Borghaei, Hossein; Barlesi, Fabrice; Kato, Terufumi; Curioni-Fontecedro, Alessandra; Sacher, Adrian; Spira, Alexander; Ramalingam, Suresh S.; Takahashi, Toshiaki; Besse, Benjamin; Anderson, Abraham; Ang, Agnes; Tran, Qui; Mather, Omar; Henary, Haby; Ngarmchamnanrith, Gataree; Friberg, Gregory; Velcheti, Vamsidhar; Govindan, Ramaswamy Share Save
Talimogene laherparepvec upregulates immune-cell populations in non-injected lesions: findings from a phase II, multicenter, open-label study in patients with stage IIIB-IVM1c melanoma Malvehy, Josep; Samoylenko, Igor; Schadendorf, Dirk; Gutzmer, Ralf; Grob, Jean-Jacques; Sacco, Joseph J.; Gorski, Kevin S.; Anderson, Abraham; Pickett, Cheryl A.; Liu, Kate; Gogas, Helen Share Save
Biomarkers associated with blinatumomab outcomes in acute lymphoblastic leukemia Wei, Andrew H.; Ribera, Josep-Maria; Larson, Richard A.; Ritchie, David; Ghobadi, Armin; Chen, Yuqi; Anderson, Abraham; Dos Santos, Cedric E.; Franklin, Janet; Kantarjian, Hagop Share Save
Durability of clinical benefit and biomarkers in patients (pts) with advanced non-small cell lung cancer (NSCLC) treated with AMG 510 (sotorasib) Hong, D. S.; Bang, Y-J.; Barlesi, F.; Durm, G.; Falchook, G. S.; Govindan, R.; Dy, G. K.; Park, K.; Strickler, J. H.; Burns, T. F.; Kim, J.; Ang, A.; Lipford, J. R.; Ngarmchamnanrith, G.; Anderson, A.; Li, B. T. Share Save
Durability of clinical benefit and biomarkers in patients (pts) with advanced non-small cell lung cancer (NSCLC) treated with AMG 510 (sotorasib) Hong, D. S.; Bang, Y-J.; Barlesi, F.; Durm, G. A.; Falchook, G. S.; Govindan, R.; Dy, G. K.; Park, K.; Strickler, J. H.; Burns, T. F.; Kim, J.; Ang, A.; Lipford, J. R.; Ngarmchamnanrith, G.; Anderson, A.; Li, B. T. Share Save
Phase 1b study of the MDM2 inhibitor AMG 232 with or without trametinib in relapsed/refractory acute myeloid leukemia Erba, Harry P.; Becker, Pamela S.; Shami, Paul J.; Grunwald, Michael R.; Flesher, Donna L.; Zhu, Min; Rasmussen, Erik; Henary, Haby A.; Anderson, Abraham A.; Wang, Eunice S. Share Save
A phase 1 study of AMG 900, an orally administered pan-aurora kinase inhibitor, in adult patients with acute myeloid leukemia Kantarjian, Hagop M.; Schuster, Michael W.; Jain, Nitin; Advani, Anjali; Jabbour, Elias; Gamelin, Erick; Rasmussen, Erik; Juan, Gloria; Anderson, Abraham; Chow, Vincent F.; Friberg, Gregory; Vogl, Florian D.; Sekeres, Mikkael A. Share Save
Share Save
CTLA-4 IS A NEGATIVE REGULATOR OF T CELL ACTIVATION IN ACUTE LIVER FAILURE Khamri, W.; Abeles, D.; Hou, T.; Anderson, A.; Bernsmeier, C.; Vergis, N.; Auzinger, G.; Bernal, W.; Willars, C.; Robinson, J.; Lombardi, G.; Sansom, D.; Wendon, J.; Thursz, M.; Antoniades, C. Share Save
A phase II study evaluating the efficacy and safety of AMG 102 (rilotumumab) in patients with recurrent glioblastoma Wen, Patrick Y.; Schiff, David; Cloughesy, Timothy F.; Raizer, Jeffrey J.; Laterra, John; Smitt, Melanie; Wolf, Michael; Oliner, Kelly S.; Anderson, Abraham; Zhu, Min; Loh, Elwyn; Reardon, David A. Share Save
A phase II study of the efficacy and safety of AMG 102 in patients with metastatic renal cell carcinoma Schoffski, Patrick; Garcia, Jorge A.; Stadler, Walter M.; Gil, Thierry; Jonasch, Eric; Tagawa, Scott T.; Smitt, Melanie; Yang, Xinqun; Oliner, Kelly S.; Anderson, Abraham; Zhu, Min; Kabbinavar, Fairooz Share Save
A genomic analysis of the archaeal system Ignicoccus hospitalis-Nanoarchaeum equitans Podar, Mircea; Anderson, Iain; Makarova, Kira S.; Elkins, James G.; Ivanova, Natalia; Wall, Mark A.; Lykidis, Athanasios; Mavromatis, Kostantinos; Sun, Hui; Hudson, Matthew E.; Chen, Wenqiong; Deciu, Cosmin; Hutchison, Don; Eads, Jonathan R.; Anderson, Abraham; Fernandes, Fillipe; Szeto, Ernest; Lapidus, Alla; Kyrpides, Nikos C.; Saier, Milton H., Jr.; Richardson, Paul M.; Rachel, Reinhard; Huber, Harald; Eisen, Jonathan A.; Koonin, Eugene V.; Keller, Martin; Stetter, Karl O. Share Save
Share Save
Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
